Taken together, our work identifies DNAJC7 as a crucial mediator of HNRNPU function and stress response pathways in human MNs and highlights HSF1 as a therapeutic target in ALS. This evidence concerns the gene HNRNPU and amyotrophic lateral sclerosis.